Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 28199491.
- Also identified by DOI 10.1093/cid/cix130.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Breakthrough invasive mold infections (IMIs) that occur during posaconazole or voriconazole prophylaxis are rare complications for which epidemiological data are lacking. This retrospective analysis comparing 24 microbiologically documented breakthrough with 66 nonbreakthrough IMIs shows a shift towards non-Aspergillus molds with a significantly increased proportion of rare multidrug-resistant molds.
Medical subject headings
- Antifungal Agents
- Azoles
- Fungi
- Invasive Fungal Infections